The Impact of the Pharmaceutical Industry on the Innovation Performance of European Countries
There are significant differences in innovation performance between countries. Additionally, the pharmaceutical sector is stronger in some countries than in others. This suggests that the development of the pharmaceutical industry can influence a country's innovation performance. Using the Global Innovation Index and selected performance measures of the pharmaceutical sector, this study examines how the pharmaceutical sector influences the innovation performance of countries from the European context. The dataset of 27 European countries was analysed using simple, and multiple linear regressions and Pearson correlation. Our findings show that only three indicators of the pharmaceutical industry, more precisely pharmaceutical Research and Development, pharmaceutical exports, and pharmaceutical employment explain the innovation performance of a country largely. Pharmaceutical Research and Development and exports have a significant positive impact on a country's innovation performance, whereas employment in the pharmaceutical industry has a slightly negative impact. Additionally, global innovation performance has been found to positively influence life expectancy. We further outline the implications and possible policy directions based on these findings.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
The impact of external innovation on new drug approvals: A retrospective analysis
Pharmaceutical companies are relying more often on external sources of innovation to boost their discovery research productivity. However, more in-depth knowledge about how external innovation may translate to successful…
The Competitiveness Analysis of the European Language Technology Market
This paper presents the key results of a study on the global competitiveness of the European Language Technology market for three areas {--} Machine Translation, speech technology, and cross-lingual search. EU competitiv…
Machine TranslationTranslationNew Horizons: Pioneering Pharmaceutical R&D with Generative AI from lab to the clinic -- an industry perspective
The rapid advance of generative AI is reshaping the strategic vision for R&D across industries. The unique challenges of pharmaceutical R&D will see applications of generative AI deliver value along the entire value chai…
Awareness and use of quantitative decision-making methods in pharmaceutical development
The pharmaceutical industry has experienced increasing costs and sustained high attrition rates in drug development over the last years. One proposal that addresses this challenge from a statistical perspective is the us…
Decision MakingA Semantic-driven Approach for Maintenance Digitalization in the Pharmaceutical Industry
The digital transformation of pharmaceutical industry is a challenging task due to the high complexity of involved elements and the strict regulatory compliance. Maintenance activities in the pharmaceutical industry play…